심혈관 수복 및 재건 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Cardiovascular Repair and Reconstruction Devices Market is presumed to reach the market size of nearly USD 7.33 Billion by 2032 from USD 4.39 Billion in 2023 with a CAGR of 5.86% under the study period 2024-2032.

Cardiovascular repair and reconstruction devices encompass a range of medical tools and implants used to treat cardiovascular diseases (CVDs) through surgical interventions. These devices are designed to repair or rebuild diseased or damaged heart valves, arteries, and other cardiac structures, restoring normal heart function and improving overall cardiovascular health. These devices are created to mend or rebuild damaged or diseased heart valves, arteries, and other cardiac structures, thereby restoring normal heart function and enhancing overall cardiovascular health. Common devices include prosthetic heart valves, stents, pacemakers, defibrillators, and cardiac patches. They are essential in managing conditions such as coronary artery disease, heart valve defects, arrhythmias, and congenital heart defects, offering patients options for both therapeutic and preventive interventions to mitigate the risks associated with CVDs.

MARKET DYNAMICS

The propelling prevalence of cardiovascular diseases and advancements in medical technology drives the cardiovascular repair and reconstruction devices market. The growing global burden of CVDs, fuelled by aging populations and lifestyle changes, amplifies demand for innovative devices that offer minimally invasive treatment options and improved patient outcomes. Technological advancements in device materials, design, and implantation techniques enhance device performance, durability, and compatibility with patient physiology. Moreover, rising healthcare expenditures and investments in cardiovascular care infrastructure worldwide provide significant growth opportunities for the expansion of the cardiovascular repair and reconstruction devices market. Governments and healthcare providers prioritize adopting advanced cardiovascular devices to address the escalating healthcare costs associated with CVD management and hospitalizations. Furthermore, increasing awareness and screening programs for early detection of cardiovascular conditions contribute to market growth. Patient education initiatives and physician training in the use of cardiovascular devices also support market penetration and adoption rates, particularly in emerging markets where access to cardiovascular care is improving. Additionally, strategic collaborations between medical device manufacturers, research institutions, and healthcare providers drive innovation and product development in the cardiovascular repair and reconstruction sector. Investments in research and clinical trials to validate the efficacy and safety of new devices further stimulate market growth and diversification. However, stringent regulatory approval processes and reimbursement challenges for new cardiovascular devices pose barriers to market growth for cardiovascular repair and reconstruction devices.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Cardiovascular Repair and Reconstruction Devices. The growth and trends of Cardiovascular Repair and Reconstruction Devices industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Cardiovascular Repair and Reconstruction Devices market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Heart Valve Repair
• Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft)
• Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches)

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cardiovascular Repair and Reconstruction Devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cardiovascular Repair and Reconstruction Devices market include Medtronic, Bard Peripheral Vascular, Terumo Cardiovascular Systems Corporation, W. L. Gore & Associates Inc., Getinge AB, CryoLife Inc., Edwards Lifesciences Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Heart Valve Repair Historic and Forecast Sales By Regions
• 5.4. Cardiovascular Grafts (Endovascular Stent Graft, Hemodialysis Access Graft, Peripheral Vascular Graft) Historic and Forecast Sales By Regions
• 5.5. Cardiovascular Patches (by Application (Cardiac Repair Patches (Atrial Septal Defect, Common Atrium, Defects of The Endocardial Cushion, Ventricular Septal Defect, Tetralogy of Fallot, Suture Bleeding), Vascular Repair Patches (Carotid Endarterectomy, Anomalous Connection of The Pulmonary Veins, Transportation of The Great Vessels, Reconstruction of The Portal and Superior Mesenteric Veins, Others) (by Raw Material (Synthetic Patches, Biological Patches) Historic and Forecast Sales By Regions

6. GLOBAL CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES MARKET ANALYSIS BY GEOGRAPHY

• 6.1. Regional Outlook
• 6.2. Introduction
• 6.3. North America Sales Analysis
  • 6.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.3.2 North America By Segment Sales Analysis
  • 6.3.3 North America By Country Sales Analysis
  • 6.3.4 United States Sales Analysis
  • 6.3.5 Canada Sales Analysis
  • 6.3.6 Mexico Sales Analysis
• 6.4. Europe Sales Analysis
  • 6.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.4.2 Europe By Segment Sales Analysis
  • 6.4.3 Europe By Country Sales Analysis
  • 6.4.4 United Kingdom Sales Analysis
  • 6.4.5 France Sales Analysis
  • 6.4.6 Germany Sales Analysis
  • 6.4.7 Italy Sales Analysis
  • 6.4.8 Russia Sales Analysis
  • 6.4.9 Rest Of Europe Sales Analysis
• 6.5. Asia Pacific Sales Analysis
  • 6.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.5.2 Asia Pacific By Segment Sales Analysis
  • 6.5.3 Asia Pacific By Country Sales Analysis
  • 6.5.4 China Sales Analysis
  • 6.5.5 India Sales Analysis
  • 6.5.6 Japan Sales Analysis
  • 6.5.7 South Korea Sales Analysis
  • 6.5.8 Australia Sales Analysis
  • 6.5.9 South East Asia Sales Analysis
  • 6.5.10 Rest Of Asia Pacific Sales Analysis
• 6.6. Latin America Sales Analysis
  • 6.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.6.2 Latin America By Segment Sales Analysis
  • 6.6.3 Latin America By Country Sales Analysis
  • 6.6.4 Brazil Sales Analysis
  • 6.6.5 Argentina Sales Analysis
  • 6.6.6 Peru Sales Analysis
  • 6.6.7 Chile Sales Analysis
  • 6.6.8 Rest of Latin America Sales Analysis
• 6.7. Middle East & Africa Sales Analysis
  • 6.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 6.7.2 Middle East & Africa By Segment Sales Analysis
  • 6.7.3 Middle East & Africa By Country Sales Analysis
  • 6.7.4 Saudi Arabia Sales Analysis
  • 6.7.5 UAE Sales Analysis
  • 6.7.6 Israel Sales Analysis
  • 6.7.7 South Africa Sales Analysis
  • 6.7.8 Rest Of Middle East And Africa Sales Analysis

7. COMPETITIVE LANDSCAPE OF THE CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES COMPANIES

• 7.1. Cardiovascular Repair and Reconstruction Devices Market Competition
• 7.2. Partnership/Collaboration/Agreement
• 7.3. Merger And Acquisitions
• 7.4. New Product Launch
• 7.5. Other Developments

8. COMPANY PROFILES OF CARDIOVASCULAR REPAIR AND RECONSTRUCTION DEVICES INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Market Concentration Rate
• 8.3. Medtronic
  • 8.3.1 Company Overview
  • 8.3.2 Company Revenue
  • 8.3.3 Products
  • 8.3.4 Recent Developments
• 8.4. Bard Peripheral Vascular
  • 8.4.1 Company Overview
  • 8.4.2 Company Revenue
  • 8.4.3 Products
  • 8.4.4 Recent Developments
• 8.5. Terumo Cardiovascular Systems Corporation
  • 8.5.1 Company Overview
  • 8.5.2 Company Revenue
  • 8.5.3 Products
  • 8.5.4 Recent Developments
• 8.6. W. L. Gore & Associates Inc.
  • 8.6.1 Company Overview
  • 8.6.2 Company Revenue
  • 8.6.3 Products
  • 8.6.4 Recent Developments
• 8.7. Getinge AB
  • 8.7.1 Company Overview
  • 8.7.2 Company Revenue
  • 8.7.3 Products
  • 8.7.4 Recent Developments
• 8.8. CryoLife Inc.
  • 8.8.1 Company Overview
  • 8.8.2 Company Revenue
  • 8.8.3 Products
  • 8.8.4 Recent Developments
• 8.9. Edwards Lifesciences Corporation
  • 8.9.1 Company Overview
  • 8.9.2 Company Revenue
  • 8.9.3 Products
  • 8.9.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies